Nacia Faure

No ORCID on file · 8 papers in corpus · active 1983-2009

Study types

  • article 6
  • book-chapter 2

Condition tags

  • endometriosis 7
article 2009
Behandlung mit einem intranasalen oder subkutan verabreichten LH-RH-Agonisten zur Unterdrückung der Ovarialfunktion bei der Behandlung der Endometriose
·doi:10.1159/000270926
article 1988
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(88)90128-7

We have previously reported reversible hypogonadism induced by the intranasal administration of the luteinizing hormone-releasing hormone agonist buserelin as a new therapeutic approach for endometriosis. Thirteen patients were randomized t…

article 1987
LH-RH agonist treatment of endometriosis.
Contributions to gynecology and obstetrics
book-chapter 1987
LH-RH Agonist Treatment of Endometriosis
·doi:10.1159/000414894
article 1986
Efficacy of different modalities of LHRH agonist (buserelin) administration on the inhibition of the pituitary-ovarian axis for the treatment of endometriosis.
Progress in clinical and biological research
book-chapter 1985
Reversible down-regulation of pituitary-ovarian function induced by repetitive LH-RH agonist administration as a new approach for treatment and study of endometriosis in the human
·doi:10.1515/9783110861488-028

Reversible down-regulation of pituitary-ovarian function induced by repetitive LH-RH agonist administration as a new approach for treatment and study of endometriosis in the human was published in LH-RH and its Analogues on page 337.

article 1984
Efficacy and safety of LHRH agcnist treatment in 10 patients with endometriosis
·doi:10.1016/0022-4731(84)90443-6
article 1983
468 Pseudo-menopause induced by repetitive intranasal insufflation of a LHRH agonist (buserelin): A new approach for treatment of endometriosis
·doi:10.1016/0022-4731(83)91969-6